Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Genomic Health, Inc.    GHDX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/05/2016 12/06/2016 12/07/2016 12/08/2016 12/09/2016 Date
30.97(c) 30.99(c) 30.59(c) 30.98(c) 30.81(c) Last
178 276 116 009 119 119 142 664 115 355 Volume
+3.20% +0.06% -1.29% +1.27% -0.55% Change
More quotes
Financials ($)
Sales 2016 329 M
EBIT 2016 -16,9 M
Net income 2016 -15,3 M
Debt 2016 4,15 M
Yield 2016 -
Sales 2017 363 M
EBIT 2017 3,45 M
Net income 2017 2,48 M
Debt 2017 11,7 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 416,91
EV / Sales2016 3,14x
EV / Sales2017 2,87x
Capitalization 1 031 M
More Financials
Company
Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions.The company has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in... 
Sector
Biotechnology & Medical Research
Calendar
12/10 | 08:30amPresentation
More about the company
Surperformance© ratings of Genomic Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on GENOMIC HEALTH, INC.
12/09 GENOMIC HEALTH : Announces Results from Multiple Oncotype DX® Studies, Reinforci..
11/29 GENOMIC HEALTH : Announces Presentation of Multiple Oncotype DX® Studies at the ..
11/10 GENOMIC HEALTH : Announces Positive Topline Clinical Validation Study Results De..
11/04 GENOMIC HEALTH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
11/03 GENOMIC HEALTH : to Present at the Credit Suisse 25th Annual Healthcare Conferen..
11/01 GENOMIC HEALTH : reports 3Q loss
11/01 GENOMIC HEALTH INC : Termination of a Material Definitive Agreement, Results of ..
11/01 GENOMIC HEALTH : Reports Third Consecutive Quarter of Double-Digit Revenue Growt..
11/01 GENOMIC HEALTH : Announces Positive Topline Clinical Validation Study Results De..
10/31 BUYINS.NET : BFS, ABCO, GHDX Expected To Be Up After Next Earnings Releases
More news
Sector news : Biotechnology & Medical Research - NEC
12/02DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/01 Pharma execs weigh in on possible changes under Trump
11/30 ACTELION : Rejecting J&J could leave Actelion with 'lot of explaining to do'
11/28 Actelion's ambitious independent-minded CEO will drive up takeover price
11/26DJWHAT'S NEWS : Business & Finance -- WSJ
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
12/09 Genomic Health shoots a few holes in Myriad-quoted study
12/09 Myriad's breast cancer test beats Genomic Health's in head-to-head study
11/01 Genomic Health's (GHDX) CEO Kim Popovits on Q3 2016 Results - Earnings Call T..
11/01 Genomic Health beats by $0.01, misses on revenue
10/31 Notable earnings after Tuesday?s close
Advertisement
Chart GENOMIC HEALTH, INC.
Duration : Period :
Genomic Health, Inc. Technical Analysis Chart | GHDX | US37244C1018 | 4-Traders
Full-screen chart
Technical analysis trends GENOMIC HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 32,6 $
Spread / Average Target 5,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kimberly J. Popovits Chairman, President & Chief Executive Officer
G. Bradley Cole Chief Operating & Financial Officer
Steven Shak Chief Scientific Officer
Phillip G. Febbo Chief Medical Officer
Amy P. Sing Senior Director-Medical Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GENOMIC HEALTH, INC.-12.47%1 031
QUINTILES IMS HOLDINGS..14.10%19 286
INCYTE CORPORATION-7.21%18 957
CELLTRION, INC.--.--%9 997
LONZA GROUP AG9.20%9 261
SEATTLE GENETICS, INC.44.54%9 183
More Results